BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14522091)

  • 21. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
    Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
    Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of HLA-E expression in human tumors.
    Marín R; Ruiz-Cabello F; Pedrinaci S; Méndez R; Jiménez P; Geraghty DE; Garrido F
    Immunogenetics; 2003 Feb; 54(11):767-75. PubMed ID: 12618909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stratification analysis of MICA triplet repeat polymorphisms and HLA antigens associated with ulcerative colitis in Japanese.
    Seki SS; Sugimura K; Ota M; Matsuzawa J; Katsuyama Y; Ishizuka K; Mochizuki T; Suzuki K; Yoneyama O; Mizuki N; Honma T; Inoko H; Asakura H
    Tissue Antigens; 2001 Aug; 58(2):71-6. PubMed ID: 11696218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of HLA genes to genetic predisposition in diffuse panbronchiolitis.
    Keicho N; Tokunaga K; Nakata K; Taguchi Y; Azuma A; Bannai M; Emi M; Ohishi N; Yazaki Y; Kudoh S
    Am J Respir Crit Care Med; 1998 Sep; 158(3):846-50. PubMed ID: 9731015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of a dominant self-ligand bound to three HLA B44 alleles and the preliminary crystallographic analysis of recombinant forms of each complex.
    Macdonald W; Williams DS; Clements CS; Gorman JJ; Kjer-Nielsen L; Brooks AG; McCluskey J; Rossjohn J; Purcell AW
    FEBS Lett; 2002 Sep; 527(1-3):27-32. PubMed ID: 12220628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of HLA-B44 subtypes associated with extended MHC haplotypes.
    Kruskall MS; Eynon EE; Awdeh Z; Alper CA; Yunis EJ
    Immunogenetics; 1987; 26(4-5):216-9. PubMed ID: 3653939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC haplotypes affect the expression of opportunistic infections in HIV patients.
    Price P; Keane NM; Stone SF; Cheong KY; French MA
    Hum Immunol; 2001 Feb; 62(2):157-64. PubMed ID: 11182226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA restriction and T-cell-receptor V beta gene expression of cytotoxic T lymphocytes reactive with human squamous-cell carcinoma of the head and neck.
    Yasumura S; Weidmann E; Hirabayashi H; Johnson JT; Herberman RB; Whiteside TL
    Int J Cancer; 1994 May; 57(3):297-305. PubMed ID: 8168988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility to idiopathic azoospermia in Japanese men is linked to HLA class I antigen.
    Miura H; Tsujimura A; Nishimura K; Kitamura M; Kondoh N; Takeyama M; Fujioka H; Sada M; Tsuji T; Matsumiya K; Takahara S; Okuyama A
    J Urol; 1998 Jun; 159(6):1939-41. PubMed ID: 9598492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of heterozygosity at 6p21.3 underlying HLA class I downregulation in gastric cancer.
    Wang XC; Zhang JQ; Shen YQ; Miao FQ; Xie W
    J Exp Clin Cancer Res; 2006 Mar; 25(1):115-9. PubMed ID: 16761627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human leukocyte antigens I and II haplotypes associated with human papillomavirus 16-positive invasive cervical cancer in Mexican women.
    Hernández-Hernández DM; Cerda-Flores RM; Juárez-Cedillo T; Granados-Arriola J; Vargas-Alarcón G; Apresa-García T; Alvarado-Cabrero I; García-Carrancá A; Salcedo-Vargas M; Mohar-Betancourt A
    Int J Gynecol Cancer; 2009 Aug; 19(6):1099-106. PubMed ID: 19820376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new HLA-C allele, Cw*1403, associated with HLA-B44 in Japanese.
    Wang H; Tokunaga K; Ishikawa Y; Lin L; Kashiwase K; Nakajima F; Ogawa A; Kuwata S; Akaza T; Tadokoro K
    Hum Immunol; 1995 Aug; 43(4):295-300. PubMed ID: 7499177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association and linkage of the HLA-A2 class I allele with autism.
    Torres AR; Sweeten TL; Cutler A; Bedke BJ; Fillmore M; Stubbs EG; Odell D
    Hum Immunol; 2006; 67(4-5):346-51. PubMed ID: 16720216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines.
    Hurks HM; Metzelaar-Blok JA; Mulder A; Claas FH; Jager MJ
    Int J Cancer; 2000 Mar; 85(5):697-702. PubMed ID: 10699951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of heterozygosity at 6p21 underlying [corrected] HLA class I downregulation in Chinese primary esophageal squamous cell carcinomas.
    Yang Y; Zhang J; Miao F; Wei J; Shen C; Shen Y; Xie W
    Tissue Antigens; 2008 Aug; 72(2):105-14. PubMed ID: 18721270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of heterozygosity in the HLA class I region in human pancreatic cancer.
    Ryschich E; Cebotari O; Fabian OV; Autschbach F; Kleeff J; Friess H; Bierhaus A; Büchler MW; Schmidt J
    Tissue Antigens; 2004 Dec; 64(6):696-702. PubMed ID: 15546343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas.
    Nie Y; Yang G; Song Y; Zhao X; So C; Liao J; Wang LD; Yang CS
    Carcinogenesis; 2001 Oct; 22(10):1615-23. PubMed ID: 11577000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human leukocyte antigen haplotypes and HFE mutations in Spanish hereditary hemochromatosis and sporadic porphyria cutanea tarda.
    Gonzalez-Hevilla M; de Salamanca RE; Morales P; Martínez-Laso J; Fontanellas A; Castro MJ; Rojo R; Moscoso J; Zamora J; Serrano-Vela JI; Arnaiz-Villena A
    J Gastroenterol Hepatol; 2005 Mar; 20(3):456-62. PubMed ID: 15740492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA class I expression in bladder carcinomas.
    Cabrera T; Pedrajas G; Cozar JM; Garrido A; Vicente J; Tallada M; Garrido F
    Tissue Antigens; 2003 Oct; 62(4):324-7. PubMed ID: 12974799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma.
    Vora AR; Rodgers S; Parker AJ; Start R; Rees RC; Murray AK
    Br J Cancer; 1997; 76(7):836-44. PubMed ID: 9328140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.